Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Cognitive Dysfunction 1Arthritis 1Agnosia 1

Interventions

Cyclophosphamide 548pembrolizumab 386Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 316Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 273Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 173Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Has results × acetaminophen, aspirin, caffeine drug combination × Clear all
NCT01264965 2020-12-11

Non-cancer Pain and Cognitive Impairment: A Disabling Relationship

University of Chicago

Phase 4 Terminated
25 enrolled 3 charts

Agnosia, Arthritis, Pain, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡